Weekly News Recap #Phispers
Novo targets MASH with up to US$ 5.2bn Akero buy; BMS acquires cell therapy developer Orbital for US$ 1.5 bn

Novo targets MASH with up to US$ 5.2bn Akero buy; BMS acquires cell therapy developer Orbital for US$ 1.5 bn

In this week’s Phispers, Novo Nordisk and Bristol Myers Squibb (BMS) struck multi-billion-dollar acquisitions to expand t...

Impressions : 1212

FDA safety review to hold up Moderna’s vaccine for teens; FDA raises concerns at Biocon’s Malaysia site

This week, Phispers has more updates from Merck. The drugmaker has temporarily withdrawn its pre-merger notification and repo...

Impressions : 1280

Cipla in FDA trouble; FDA-backed cannabis drug posts strong sales in launch year

This week, Phispers brings you an update on the mysterious respiratory infection as over 500 people get infected by the coronav...

Impressions : 3619

FDA approves first flu drug in 20 years; Trump proposes global index to check drug price rise

This week, Phispers brings you news on US President Donald Trump’s new payment model, proposed ahead of the midterm polls...

Impressions : 6506